Disease Awareness

Novartis at ASCO and EHA 2022

Driven by our passion for patients and grounded in our industry-leading pipeline of 45+ different compounds across 70+ development programs, Novartis is rapidly advancing novel cancer treatment approaches in areas of great medical need.

CancerDisease AwarenessDrug DevelopmentOncology
Access to Healthcare

Breaking down barriers for patients with sickle cell disease

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

Access to HealthcareDisease AwarenessGenetic DiseaseLiving With DiseasePatient Voices
Access to Healthcare

Demystifying the science of myelodysplastic syndromes

Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.

CancerDisease AwarenessFuture of HealthcareOncologyPatient Education
Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

Basel, October 21, 2021 — Novartis announced today that it has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the COVID-19 pandemic by expanding its support of the fill and finish of the Pfizer-BioNTech COVID-19 vaccine. Novartis will use its sterile manufacturing facilities at its Novartis Technical…

Global Health PartnershipsDisease AwarenessAccess to Healthcare
Novartis Cosentyx® builds on its axSpA leadership with US label update for dosing flexibility in ankylosing spondylitis

Basel, January 31, 2020 — Novartis, a leader in rheumatology and immuno-dermatology, announced today that the US Food and Drug Administration (FDA) has approved a label update for Cosentyx® (secukinumab) to include the option for up-titration to a 300 mg dose for adults with active ankylosing spondylitis (AS).

Disease AwarenessChronic Illness
Patient Perspectives

Photographer Captures Patients Around the World Persevering With ITP

To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Chronic IllnessDisease AwarenessLiving With DiseasePatient EducationPatient Voices
Patient Perspectives

A blood cancer patient’s long road to diagnosis

Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer

CancerDisease AwarenessLiving With DiseasePatient VoicesRare Diseases
Access to Healthcare

Positive gains are needed to accelerate change for women with lung disease

COPD receives low attention as a women’s health issue. It’s time to change that.

Chronic IllnessDisease AwarenessEthical BusinessRespiratoryWomen in Science
Patient Perspectives

Turning the sound up on patient voices in lung cancer research and development

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Disease AwarenessOncologyPatient VoicesClinical TrialsDrug Development
Patient Perspectives

Your Genes, Your Melanoma

Learn about the role of precision oncology in advanced melanoma treatment.

CancerDisease AwarenessLiving With DiseaseOncologyPatient EducationTargeted TherapyGene Testing
Patient Perspectives

Speaking Up in CML

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

CancerDisease AwarenessLiving With DiseaseOncologyPatient Voices
Patient Perspectives

The realities of living with premenopausal metastatic breast cancer

Receiving a breast cancer diagnosis is difficult, but these young women faced an especially challenging diagnosis: stage IV metastatic breast cancer.

CancerDisease AwarenessLiving With DiseaseOncologyPatient Voices